Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL395853 | 0.77 | TSHR (0.61) | TSHRGABRA1GABRB2KDM4EL3MBTL1 | |
| SCHEMBL20181886 | 0.77 | ADRB2 (0.44) | TSHRTAAR1LMNACYP1A2PGR | |
| SCHEMBL20637313 | 0.77 | TSHR (0.41) | TSHRTAAR1HKDC1GABRA1GABRB2 | |
| SCHEMBL983639 | 0.77 | TSHR (0.67) | TSHRTAAR1HKDC1GABRA1GABRB2 | |
| SCHEMBL5667510 | 0.77 | ALDH1A1 (0.41) | TSHRTAAR1HKDC1GABRA1GABRB2 | |
| SCHEMBL21275538 | 0.75 | CA1 (0.46) | TSHRPTGS1TDP1L3MBTL1 | |
| SCHEMBL8094585 | 0.75 | TSHR (0.40) | TSHRCYP3A4KMT2AMEN1TRPA1 | |
| SCHEMBL2697178 | 0.75 | TSHR (0.41) | TSHRGABRA1GABRB2LMNAL3MBTL1 | |
| SCHEMBL2186068 | 0.75 | GPR84 (0.44) | TSHRLMNATDP1KMT2AMEN1 | |
| SCHEMBL8087556 | 0.74 | ALDH1A1 (0.40) | TSHRCYP3A4ALOX15KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2226328-B1 | PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND | ASAHI KASEI CHEMICALS CORP (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-8168812-B2 | Process for producing alkyl tin alkoxide compound and process for producing carbonic acid ester using said compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-20100292496-A1 | Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-2226328-A1 | PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND | Asahi Kasei Chemicals Corporation (JP) | 2010-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292496-A1 | Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound | OXSR1, AOC2, OXER1 | TSHR 249/4885TAAR1 47/4885HKDC1 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.